APRICollaboration•prnewswire•
Apriori Bio Announces Collaboration with the Francis Crick Institute
Sentiment:Positive (70)
Summary
Apriori to leverage foundational insights from the Crick's Legacy Study to further validate Octavia™ platform's ability to predict viral evolution and vaccine performance CAMBRIDGE, Mass., Aug. 12, 2025 /PRNewswire/ -- Apriori Bio, a biotechnology company focused on developing...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 12, 2025 by prnewswire